IP Verse

Subcutaneous Her2 Antibody Formulations

Patent No. EP3570884 (titled "Subcutaneous Her2 Antibody Formulations") was filed by F Hoffmann LA Roche on Jan 16, 2018. The application was issued on Sep 30, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLEJun 30, 2021HOFFMANN EITLE
POHLMANJun 30, 2021POHLMAN
WITHERS & ROGERSJun 28, 2021TOMBLING
KONIG SZYNKA TILMANN VON RENESSEApr 22, 2021KONIG SZYNKA TILMANN VON RENESSE DUSSELDORF
KONIG SZYNKA TILMANN VON RENESSEApr 22, 2021KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3570884

F HOFFMANN LA ROCHE
Application Number
EP18713735A
Filing Date
Jan 16, 2018
Status
Granted And Under Opposition
Aug 28, 2020
Publication Date
Sep 30, 2020
External Links
Slate, Register , Google Patents